Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.
2.
4.

[Tumor necrosis factor alpha genetic polymorphism as a risk factor in disease].

Aguillón JC, Cruzat A, Cuenca J, Cuchacovich M.

Rev Med Chil. 2002 Sep;130(9):1043-50. Review. Spanish.

PMID:
12434654
5.

Tumour necrosis factor gene polymorphism and disease prevalence.

Qidwai T, Khan F.

Scand J Immunol. 2011 Dec;74(6):522-47. doi: 10.1111/j.1365-3083.2011.02602.x. Review.

6.

Could single-nucleotide polymorphisms (SNPs) affecting the tumour necrosis factor promoter be considered as part of rheumatoid arthritis evolution?

Aguillón JC, Cruzat A, Aravena O, Salazar L, Llanos C, Cuchacovich M.

Immunobiology. 2006;211(1-2):75-84. Epub 2005 Dec 27. Review.

PMID:
16446172
7.

Genetics of tumour necrosis factor-alpha in autoimmune, infectious, and neoplastic diseases.

Wilson AG, di Giovine FS, Duff GW.

J Inflamm. 1995;45(1):1-12. Review.

PMID:
7583349
8.

Tumor necrosis factor alpha -308 gene locus promoter polymorphism: an analysis of association with health and disease.

Elahi MM, Asotra K, Matata BM, Mastana SS.

Biochim Biophys Acta. 2009 Mar;1792(3):163-72. Review.

PMID:
19708125
9.

Recent progress in the tumor necrosis factor-alpha field.

Rink L, Kirchner H.

Int Arch Allergy Immunol. 1996 Nov;111(3):199-209. Review.

PMID:
8917114
10.

Tumour necrosis factor alpha and mucocutaneous leishmaniasis.

Blackwell JM.

Parasitol Today. 1999 Feb;15(2):73-5. Review.

PMID:
10234190
11.

Genetics of tumour necrosis factor (TNF) in autoimmune liver diseases: red hot or red herring?

Wilson AG.

J Hepatol. 1999 Feb;30(2):331-3. Review. No abstract available.

PMID:
10068116
12.

Human catalase, its polymorphisms, regulation and changes of its activity in different diseases.

Kodydková J, Vávrová L, Kocík M, Žák A.

Folia Biol (Praha). 2014;60(4):153-67. Review.

Supplemental Content

Support Center